Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in a healthcare worker population exceeded self-reported infection rates, 2020

Susan E Hoover; Valerie Reed

doi:10.1017/ash.2022.9

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in a healthcare worker population exceeded self-reported infection rates, 2020

Antimicrob Steward Healthc Epidemiol. 2022 Feb 7;2(1):e21. doi: 10.1017/ash.2022.9. eCollection 2022.

Authors

Susan E Hoover¹, Valerie Reed¹

Affiliation

¹ Sanford Health, Sioux Falls, South Dakota.

Abstract

A study of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence at a healthcare institution prior to the availability of vaccine showed that seroprevalence in the cohort increased over 6 months from 25% to 55%. The number of employees with antibodies was higher than the number who reported an exposure or diagnosis at each time point.